Delta Score: Improving the Binding Assessment of Structure-Based Drug Design Methods
Structure-based drug design (SBDD) stands at the forefront of drug discovery, emphasizing the creation of molecules that target specific binding pockets. Recent advances in this area have witnessed the adoption of deep generative models and geometric deep learning techniques, modeling SBDD as a conditional generation task where the target structure serves as context. Historically, evaluation of these models centered on docking scores, which quantitatively depict the predicted binding affinity between a molecule and its target pocket. Though state-of-the-art models purport that a majority of their generated ligands exceed the docking score of ground truth ligands in test sets, it begs the question: Do these scores align with real-world biological needs? In this paper, we introduce the delta score, a novel evaluation metric grounded in tangible pharmaceutical requisites. Our experiments reveal that molecules produced by current deep generative models significantly lag behind ground truth reference ligands when assessed with the delta score. This novel metric not only complements existing benchmarks but also provides a pivotal direction for subsequent research in the domain.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DesignDrug DiscoveryMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Rethinking Specificity in SBDD: Leveraging Delta Score and Energy-Guided Diffusion
In the field of Structure-based Drug Design (SBDD), deep learning-based generative models have achieved outstanding performance in terms of docking score. However, further study shows that the existing molecular generati…
Contrastive LearningDrug DesignSpecificityFlowDock: Geometric Flow Matching for Generative Protein-Ligand Docking and Affinity Prediction
Powerful generative AI models of protein-ligand structure have recently been proposed, but few of these methods support both flexible protein-ligand docking and affinity estimation. Of those that do, none can directly mo…
Blind DockingDrug DiscoveryDeltaDock: A Unified Framework for Accurate, Efficient, and Physically Reliable Molecular Docking
Molecular docking, a technique for predicting ligand binding poses, is crucial in structure-based drug design for understanding protein-ligand interactions. Recent advancements in docking methods, particularly those leve…
Blind DockingDrug DesignMolecular DockingPrediction+1DrugGen enhances drug discovery with large language models and reinforcement learning
Traditional drug design faces significant challenges due to inherent chemical and biological complexities, often resulting in high failure rates in clinical trials. Deep learning advancements, particularly generative mod…
Drug DesignDrug DiscoveryvalidDrugGen: Advancing Drug Discovery with Large Language Models and Reinforcement Learning Feedback
Traditional drug design faces significant challenges due to inherent chemical and biological complexities, often resulting in high failure rates in clinical trials. Deep learning advancements, particularly generative mod…
Drug DesignDrug Discovery